276 related articles for article (PubMed ID: 20154415)
1. [Transporters involved in hepatobiliary transport of drugs].
Maeda K
Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):76-9. PubMed ID: 20154415
[No Abstract] [Full Text] [Related]
2. [Significant role of transporters in drug hepatobiliary transport].
Sun J; Sun YB; He ZG
Yao Xue Xue Bao; 2005 Aug; 40(8):680-5. PubMed ID: 16268499
[No Abstract] [Full Text] [Related]
3. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
[TBL] [Abstract][Full Text] [Related]
4. [Role of transporters in hepatic drug disposition].
Gao CY; Chen XY; Zhong DF
Yao Xue Xue Bao; 2012 May; 47(5):565-72. PubMed ID: 22811997
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin.
Wlcek K; Koller F; Ferenci P; Stieger B
Drug Metab Dispos; 2013 Aug; 41(8):1522-8. PubMed ID: 23695864
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.
Maeda K; Sugiyama Y
Drug Metab Pharmacokinet; 2008; 23(4):223-35. PubMed ID: 18762709
[TBL] [Abstract][Full Text] [Related]
7. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier transporters and response to CNS-active drugs.
Urquhart BL; Kim RB
Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms on drug transporters in the drug absorption and disposition].
Masuda S; Inui K
Nihon Rinsho; 2002 Jan; 60(1):65-73. PubMed ID: 11808341
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of multidrug resistance transporters at the blood-brain barriers.
Scherrmann JM
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):233-46. PubMed ID: 16922639
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.
Ulloa JL; Stahl S; Yates J; Woodhouse N; Kenna JG; Jones HB; Waterton JC; Hockings PD
NMR Biomed; 2013 Oct; 26(10):1258-70. PubMed ID: 23564602
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.
Ieiri I; Higuchi S; Sugiyama Y
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037
[TBL] [Abstract][Full Text] [Related]
13. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
[No Abstract] [Full Text] [Related]
16. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
Haufroid V
Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.
Yamazaki M; Suzuki H; Sugiyama Y
Pharm Res; 1996 Apr; 13(4):497-513. PubMed ID: 8710738
[TBL] [Abstract][Full Text] [Related]
18. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport.
Beukeveld GJ; In 't Veld G; Havinga R; Groen AK; Wolthers BG; Kuipers F
J Hepatol; 1996 Mar; 24(3):343-52. PubMed ID: 8778203
[TBL] [Abstract][Full Text] [Related]
19. Role for drug transporters beyond tumor resistance: hepatic functional imaging and genotyping of multidrug resistance transporters for the prediction of irinotecan toxicity.
Kroetz DL
J Clin Oncol; 2006 Sep; 24(26):4225-7. PubMed ID: 16895999
[No Abstract] [Full Text] [Related]
20. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
Bucher S; Le Vee M; Jouan E; Fardel O
J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
